Patent application number | Description | Published |
20110294812 | P38 MAP KINASE INHIBITORS - The invention relates to compounds of formula (I): | 12-01-2011 |
20120136031 | P38MAP KINASE INHIBITOR - The present invention relates to a compound of formula (I): | 05-31-2012 |
20120208799 | COMPOUNDS - The present invention relates to compounds of formula (I) | 08-16-2012 |
20130029990 | PYRAZOLE P38 MAP KINASE INHIBITORS - There are provided inter alia compounds of formula (I): wherein R | 01-31-2013 |
20130040962 | P38 MAP Kinase Inhibitors - There is provided a compound of formula (I): wherein: J represents (A): or (B): compositions comprising same, processes for preparing said compounds and use thereof in treatment, particularly in the treatment of inflammatory disease, such as asthma, COPD and 15 rheumatoid arthritis. | 02-14-2013 |
20130040995 | NOVEL COMPOUNDS - There is provided inter alia a compound of formula (I): | 02-14-2013 |
20140057915 | KINASE INHIBITORS - There are provided compounds of formula I, | 02-27-2014 |
20140249164 | COMPOUNDS - The present invention relates to compounds of formula (I) | 09-04-2014 |
20140249169 | 1-PYRAZOLYL-3- (4- ((2 -ANILINOPYRIMIDIN- 4 - YL) OXY) NAPTHTHALEN- 1- YL) UREAS AS P38 MAP KINASE INHIBITORS - There is provided a compound of formula (I) which is an inhibitor of the family of p38 mitogen-activated protein kinase enzymes, and to its use in therapy, including in pharmaceutical combinations, especially in the treatment of inflammatory diseases, including inflammatory diseases of the lung, such as asthma and COPD. | 09-04-2014 |